These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12137753)

  • 1. Tumour necrosis factor alpha is not an essential component of verotoxin 1-induced toxicity in mice.
    Wolski VM; Soltyk AM; Brunton JL
    Microb Pathog; 2002 Jun; 32(6):263-71. PubMed ID: 12137753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verotoxin 1 from Escherichia coli affects Gb3/CD77+ bovine lymphocytes independent of interleukin-2, tumor necrosis factor-alpha, and interferon-alpha.
    Menge C; Stamm I; Blessenohl M; Wieler LH; Baljer G
    Exp Biol Med (Maywood); 2003 Apr; 228(4):377-86. PubMed ID: 12671182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.
    Rutjes NW; Binnington BA; Smith CR; Maloney MD; Lingwood CA
    Kidney Int; 2002 Sep; 62(3):832-45. PubMed ID: 12164865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage.
    Lentz EK; Cherla RP; Jaspers V; Weeks BR; Tesh VL
    Infect Immun; 2010 Sep; 78(9):3689-99. PubMed ID: 20605983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157:H7 in mice.
    Kuribayashi T; Seita T; Fukuyama M; Furuhata K; Honda M; Matsumoto M; Seguchi H; Yamamoto S
    J Infect Chemother; 2006 Oct; 12(5):251-6. PubMed ID: 17109087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against verocytotoxin in mice induced by liposome-coupled verocytotoxin.
    Naito S; Horino A; Komiya T; Fukuda Y; Takahashi M; Ami Y; Suzaki Y; Satoh S; Gondaira F; Sugiyama J; Nakano Y; Mori M; Awai K; Nishinohara S; Komuro K; Uchida T
    Int Arch Allergy Immunol; 1997 Nov; 114(3):293-7. PubMed ID: 9363912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of gamma interferon and tumor necrosis factor-alpha in shiga toxin lethality.
    Sasaki S; Omoe K; Tagawa Yi; Iwakura Y; Sekikawa K; Shinagawa K; Nakane A
    Microb Pathog; 2002 Jul; 33(1):43-7. PubMed ID: 12127799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha.
    Landoni VI; de Campos-Nebel M; Schierloh P; Calatayud C; Fernandez GC; Ramos MV; Rearte B; Palermo MS; Isturiz MA
    Infect Immun; 2010 Mar; 78(3):1193-201. PubMed ID: 20008539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine antibody responses to the verotoxin 1 B subunit: demonstration of major histocompatibility complex dependence and an immunodominant epitope involving phenylalanine 30.
    Bast DJ; Sandhu J; Hozumi N; Barber B; Brunton J
    Infect Immun; 1997 Jul; 65(7):2978-82. PubMed ID: 9199476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells.
    Eisenhauer PB; Jacewicz MS; Conn KJ; Koul O; Wells JM; Fine RE; Newburg DS
    Microb Pathog; 2004 Apr; 36(4):189-96. PubMed ID: 15001224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
    Bast DJ; Brunton JL; Karmali MA; Richardson SE
    Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse toxicity and cytokine release by verotoxin 1 B subunit mutants.
    Wolski VM; Soltyk AM; Brunton JL
    Infect Immun; 2001 Jan; 69(1):579-83. PubMed ID: 11119557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interaction between Escherichia coli verotoxin and lipopolysaccharide on cytokine induction and lethality in mice.
    Suzuki K; Tateda K; Matsumoto T; Gondaira F; Tsujimoto S; Yamaguchi K
    J Med Microbiol; 2000 Oct; 49(10):905-910. PubMed ID: 11023187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.
    Itoh K; Tezuka T; Inoue K; Tada H; Suzuki T
    Tohoku J Exp Med; 2001 Dec; 195(4):237-43. PubMed ID: 11908825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid.
    Ludwig K; Karmali MA; Smith CR; Petric M
    Can J Microbiol; 2002 Jan; 48(1):99-103. PubMed ID: 11888169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia.
    Smith SR; Terminelli C; Kenworthy-Bott L; Calzetta A; Donkin J
    J Leukoc Biol; 1994 Jun; 55(6):711-8. PubMed ID: 8195696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verotoxin activates mitogen-activated protein kinase in human peripheral blood monocytes: role in apoptosis and proinflammatory cytokine release.
    Cameron P; Smith SJ; Giembycz MA; Rotondo D; Plevin R
    Br J Pharmacol; 2003 Dec; 140(7):1320-30. PubMed ID: 14597601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies.
    Byun Y; Ohmura M; Fujihashi K; Yamamoto S; McGhee JR; Udaka S; Kiyono H; Takeda Y; Kohsaka T; Yuki Y
    Vaccine; 2001 Feb; 19(15-16):2061-70. PubMed ID: 11228378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shiga toxin 1-induced activation of c-Jun NH(2)-terminal kinase and p38 in the human monocytic cell line THP-1: possible involvement in the production of TNF-alpha.
    Foster GH; Tesh VL
    J Leukoc Biol; 2002 Jan; 71(1):107-14. PubMed ID: 11781386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker.
    Heath-Engel HM; Lingwood CA
    Angiogenesis; 2003; 6(2):129-41. PubMed ID: 14739619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.